Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
57%(4 trials)

Phase Distribution

Ph phase_3
1
14%
Ph phase_1
5
71%
Ph phase_2
1
14%

Phase Distribution

5

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
5(71.4%)
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
1(14.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(7)

Detailed Status

Completed7

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 15 (71.4%)
Phase 21 (14.3%)
Phase 31 (14.3%)

Trials by Status

completed7100%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_3

Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan

NCT00356603
completedphase_1

Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy Adults

NCT01381796
completedphase_1

Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®

NCT00546650
completedphase_1

Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period

NCT00723983
completedphase_2

Study of NXN 188 for the Treatment of Migraine With Aura

NCT00920686
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT00356603Phase 3

Study Of Sumatriptan Succinate Injection Kit In Patients With Migraine or Cluster Headache In Japan

Completed
NCT01381796Phase 1

Compare PK and Bioavailability of 2 NP101 Patches With Oral Imitrex in Healthy Adults

Completed
NCT00546650Phase 1

Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®

Completed
NCT00723983Phase 1

Phase I, Open Label, Single-Dose, Four Way Crossover Study to Compare the PK of NP101 With Oral Imitrex® (50mg) in Migraine Subjects During an Acute Migraine Attack and During a Non-Migraine Period

Completed
NCT00920686Phase 2

Study of NXN 188 for the Treatment of Migraine With Aura

Completed
NCT00847405Phase 1

Sumatriptan Succinate 100 mg Tablets Under Fasting Conditions

Completed
NCT00846885Phase 1

Sumatriptan Succinate 100 mg Tablets Under Non-Fasting Conditions

Completed

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7